Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001086364-24-006038
Filing Date
2024-01-31
Accepted
2024-01-31 14:08:26
Documents
1

Document Format Files

Seq Description Document Type Size
1 us17322u2078_013124.txt SC 13G 11504
  Complete submission text file 0001086364-24-006038.txt   13512
Mailing Address 50 HUDSON YARDS NEW YORK NY 10001
Business Address 50 HUDSON YARDS NEW YORK NY 10001 212-810-5300
BlackRock Inc. (Filed by) CIK: 0001364742 (see all company filings)

EIN.: 320174431 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G
SIC: 6211 Security Brokers, Dealers & Flotation Companies
(CF Office: 02 Finance)

Mailing Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016
Business Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016 (908) 967-6676
Citius Pharmaceuticals, Inc. (Subject) CIK: 0001506251 (see all company filings)

EIN.: 273425913 | State of Incorp.: NV | Fiscal Year End: 0930
Type: SC 13G | Act: 34 | File No.: 005-90253 | Film No.: 24582148
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)